Endovascular treatment for TASC Ⅱ C/D femoropopliteal arterial disease
10.3760/cma.j.issn.1007-631X.2012.08.003
- VernacularTitle:腔内支架植入治疗TASCⅡ C、D型股腘动脉慢性闭塞病变
- Author:
Tong XING
;
Baozhong YANG
;
Shenghan SONG
;
Chuanjun LIAO
- Publication Type:Journal Article
- Keywords:
Arteriosclerosis obliterans;
Angioplasty,balloon;
Stents;
Patency rate
- From:
Chinese Journal of General Surgery
2012;27(8):616-618
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo evaluate endovascular stenting for TASC TASC Ⅱ C/D femoropopliteal arterial disease.MethodsBetween January 2008 and June 2011,Endovascular treatments of 51 limbs TASC Ⅱ C/D femoropopliteal artery occlusions in 46 patients(27 male and 19 female) were retrospectively reviewed.Mean age was (70 ± 8 ) years ( range,52 years to 88 years).Severe intermittent claudication,rest pain,minor tissue defect and foot ulceration or gangrene were in 29 limbs,12 limbs,6 limbs and 4 limbs,respectively. Technical success rate,ankle brachial index (ABI),complication rate, and cumulative primary patency rate were evaluated. ResultsTechnical success rate was 90.2％.93 stents were placed in 46 limbs of the 42 patients.Postoperative ABI was increased in all patients.42 patients(46 lower limbs) were followed up for a mean period of 14.6 months.Primary,assisted-primary,and cumulative patency rates at 6 months were 81.0％,88.1％ and 90.5％.Primary,assisted-primary,and cumulative patency rates at 12 months were 66.7％,71.8％ and 79.5％ respectively. ConclusionsEndovascular treatment of TASC Ⅱ C/D femoropopliteal arterial lesions is microinvasive,safe and effective.
